Document Detail


Effects of hyperbaric oxygen therapy on the treatment of severe cases of periodontitis.
MedLine Citation:
PMID:  20462143     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To evaluate the effect of hyperbaric oxygen therapy (HBO2) as an adjunct to scaling and root planing (SRP) in the treatment of severe cases of chronic periodontitis. MATERIALS AND METHODS: In 20 patients diagnosed with severe generalized chronic periodontitis (pockets>7mm) with bleeding on probing, SRP was rendered in all pockets. Additionally, five consecutive hyperbaric sessions were administered in 10 patients after random allocation (SRP + HBO2). Clinical parameters were assessed at baseline up to six months: plaque index, bleeding on probing, probing depth, clinical attachment level and benzoyl-DL-arginine-naphthylamide (BANA) test. RESULTS: SRP + HBO2 resulted in greater probing reduction and attachment gain than SRP alone three months after treatment (p<0.001). The BANA test was negative after one week only for sites in the SRP + HBO2 group (p<0.05). However, SRP + HBO2 failed to show a significant difference from SRP group after 3 months, where all BANA sites became negative (p>0.05). CONCLUSION: Our data suggest that hyperbaric oxygen therapy had a short-term beneficial effect on pocket reduction and bacterial elimination, and may be considered a potential adjunct therapeutic option to improve the clinical outcomes of scaling in severe cases of chronic periodontitis.
Authors:
Getulio R Nogueira-Filho; Bruno T Rosa; Joao R David-Neto
Related Documents :
20684513 - Orthogonal photocleavage of a monochromophoric linker.
17658183 - Aggressive periodontitis associated with papillon-lefèvre syndrome: report of a 14-yea...
15307393 - Monovision laser in situ keratomileusis for pre-presbyopic and presbyopic patients.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc     Volume:  37     ISSN:  1066-2936     ISO Abbreviation:  Undersea Hyperb Med     Publication Date:    2010 Mar-Apr
Date Detail:
Created Date:  2010-05-13     Completed Date:  2010-06-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312954     Medline TA:  Undersea Hyperb Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  107-14     Citation Subset:  IM; S    
Affiliation:
Department of Dental Diagnostic and Surgical Sciences, University of Manitoba, Canada. nogueira@cc.umanitoba.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Benzoylarginine-2-Naphthylamide / diagnostic use
Brazil
Chronic Periodontitis / diagnosis,  microbiology,  therapy*
Dental Scaling / methods
Female
Humans
Hyperbaric Oxygenation / methods*
Male
Pilot Projects
Root Planing / methods
Single-Blind Method
Chemical
Reg. No./Substance:
305-09-9/Benzoylarginine-2-Naphthylamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperbaric oxygen therapy and age-related macular degeneration.
Next Document:  Treating necrotizing fasciitis with or without hyperbaric oxygen therapy.